229 related articles for article (PubMed ID: 33327623)
21. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
Hino K; Horigome K; Nishio M; Komura S; Nagata S; Zhao C; Jin Y; Kawakami K; Yamada Y; Ohta A; Toguchida J; Ikeya M
J Clin Invest; 2017 Sep; 127(9):3339-3352. PubMed ID: 28758906
[TBL] [Abstract][Full Text] [Related]
22. Clinical Aspects and Current Therapeutic Approaches for FOP.
Kitoh H
Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32887348
[TBL] [Abstract][Full Text] [Related]
23. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.
Hatsell SJ; Idone V; Wolken DM; Huang L; Kim HJ; Wang L; Wen X; Nannuru KC; Jimenez J; Xie L; Das N; Makhoul G; Chernomorsky R; D'Ambrosio D; Corpina RA; Schoenherr CJ; Feeley K; Yu PB; Yancopoulos GD; Murphy AJ; Economides AN
Sci Transl Med; 2015 Sep; 7(303):303ra137. PubMed ID: 26333933
[TBL] [Abstract][Full Text] [Related]
24. ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva.
Pang J; Zuo Y; Chen Y; Song L; Zhu Q; Yu J; Shan C; Cai Z; Hao J; Kaplan FS; Shore EM; Zhang K
Bone; 2016 Nov; 92():29-36. PubMed ID: 27492611
[TBL] [Abstract][Full Text] [Related]
25. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings.
Amalfitano M; Fyfe B; Thomas SV; Egan KP; Xu M; Smith AG; Kaplan FS; Shore EM; Pignolo RJ
Bone; 2018 Apr; 109():56-60. PubMed ID: 29320714
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification.
Gupta A; Zimmermann MT; Wang H; Broski SM; Sigafoos AN; Macklin SK; Urrutia RA; Clark KJ; Atwal PS; Pignolo RJ; Klee EW
Am J Med Genet A; 2019 Sep; 179(9):1764-1777. PubMed ID: 31240838
[TBL] [Abstract][Full Text] [Related]
27. Recent Topics in Fibrodysplasia Ossificans Progressiva.
Katagiri T; Tsukamoto S; Nakachi Y; Kuratani M
Endocrinol Metab (Seoul); 2018 Sep; 33(3):331-338. PubMed ID: 30229572
[TBL] [Abstract][Full Text] [Related]
28. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.
Al Mukaddam M; Rajapakse CS; Pignolo RJ; Kaplan FS; Smith SE
Bone; 2018 Apr; 109():147-152. PubMed ID: 28822792
[TBL] [Abstract][Full Text] [Related]
29. Fibrodysplasia ossificans progressiva: a current review of imaging findings.
Bauer AH; Bonham J; Gutierrez L; Hsiao EC; Motamedi D
Skeletal Radiol; 2018 Aug; 47(8):1043-1050. PubMed ID: 29445932
[TBL] [Abstract][Full Text] [Related]
30. Fibrodysplasia ossificans progressiva (stone man syndrome): a case report.
Shah ZA; Rausch S; Arif U; El Yafawi B
J Med Case Rep; 2019 Dec; 13(1):364. PubMed ID: 31785620
[TBL] [Abstract][Full Text] [Related]
31. BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints.
Agarwal S; Loder SJ; Brownley C; Eboda O; Peterson JR; Hayano S; Wu B; Zhao B; Kaartinen V; Wong VC; Mishina Y; Levi B
Dev Biol; 2015 Apr; 400(2):202-9. PubMed ID: 25722188
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a novel model of chondrogenesis using murine embryonic stem cells carrying fibrodysplasia ossificans progressiva-associated mutant ALK2.
Fujimoto M; Ohte S; Shin M; Yoneyama K; Osawa K; Miyamoto A; Tsukamoto S; Mizuta T; Kokabu S; Machiya A; Okuda A; Suda N; Katagiri T
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):347-52. PubMed ID: 25446088
[TBL] [Abstract][Full Text] [Related]
33. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
[TBL] [Abstract][Full Text] [Related]
34. Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva.
de Vries TJ; Schoenmaker T; Micha D; Hogervorst J; Bouskla S; Forouzanfar T; Pals G; Netelenbos C; Eekhoff EMW; Bravenboer N
Bone; 2018 Apr; 109():168-177. PubMed ID: 28705683
[TBL] [Abstract][Full Text] [Related]
35. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call.
Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS
Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy in fibrodysplasia ossificans progressiva.
Muglu JA; Garg A; Pandiarajan T; Shore EM; Kaplan FS; Uchil D; Dickson MJ
Obstet Med; 2012 Mar; 5(1):35-8. PubMed ID: 27579132
[TBL] [Abstract][Full Text] [Related]
37. Identification of the Identical Human Mutation in
Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM
Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133
[TBL] [Abstract][Full Text] [Related]
38. ACVR1 Function in Health and Disease.
Valer JA; Sánchez-de-Diego C; Pimenta-Lopes C; Rosa JL; Ventura F
Cells; 2019 Oct; 8(11):. PubMed ID: 31683698
[No Abstract] [Full Text] [Related]
39. Genetic disorders with heterotopic ossificans.
Sankar R; Gowrishankar K; Viswanathan S
Indian J Orthop; 2015; 49(3):361-4. PubMed ID: 26015640
[TBL] [Abstract][Full Text] [Related]
40. [Fibrodysplasia ossificans progressiva and osteoimmunology].
Katagiri T
Clin Calcium; 2016 May; 26(5):691-8. PubMed ID: 27117614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
